Wed, Jul 26, 2023
Dr Reddy's Laboratories on Wednesday reported an 18 per cent increase in consolidated profit after tax at Rs 1,405 crore in the June quarter, fuelled by US generics and strong performance in Russia.
More >
Mon, Oct 31, 2022
Dr Reddy share price: Dr Reddy's stock was trading in green on both the indices with more than 1 per cent surge.
Fri, Oct 26, 2018
Dr Reddys Laboratories Limited Friday said its profit after tax for the quarter ended September 30 was up by 77 per cent to Rs 504 crore against Rs 387.6 crore in the second quarter of FY18.
Fri, May 12, 2017
GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”
In Q3FY17, the company reported consolidated net profit of Rs 492.3 crore, down 15.94% year-on-year compared to Rs 585.7 crore in the corresponding period of the previous year.
Tue, Oct 25, 2016
Dr Reddy's Laboratories today reported a decline of 60.12 per cent in consolidated net profit for the September quarter at Rs 308.9 crore, mainly because of drop in sales in Venezuela and North America.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
